KDT-3594 clinical trials
Also written KDT-3594.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2017
How each study uses KDT-3594 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- KDT-3594
- 4
Studies by the year they started
4 studies that test it; most in 2017 (1)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses KDT-3594 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's DiseaseCompletedPhase 2Kissei Pharmaceutical Co., Ltd.NCT06722729Written as KDT-3594
- A Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's DiseaseCompletedPhase 2Kissei Pharmaceutical Co., Ltd.NCT04867551Written as KDT-3594
- A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.CompletedPhase 2Kissei Pharmaceutical Co., Ltd.NCT03845387Written as KDT-3594
- Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's DiseaseCompletedPhase 1Kissei Pharmaceutical Co., Ltd.NCT03068481Written as KDT-3594